• SR One Capital Management, a 10% owner of Odyssey Therapeutics, reported a jump in beneficial ownership tied to its pre-IPO holdings converting into common stock on May 11, 2026.
• Holdings reported through affiliated funds rose to 1,831,383 shares, 574,314 shares, and 1,014,851 shares following the transactions.
• Form 4 also showed small net-exercise withholdings for warrant exercises, including 1,065 shares, 277 shares, and 438 shares withheld.
• SR One Capital Management reported open-market purchases at USD 18, including 222,222 shares, 133,333 shares, and 200,000 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Odyssey Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-217656), on May 11, 2026, and is solely responsible for the information contained therein.